发明名称 |
Polypeptides, antibody variable domains and antagonists |
摘要 |
The invention relates to anti-TNFR1 polypeptides and antibody single variable domains (dAbs) that are resistant to degradation by a protease, as well as antagonists comprising these. The polypeptides, dAbs and antagonists are useful for as therapeutics and/or prophylactics that are likely to encounter proteases when administered to a patient, for example for pulmonary administration, oral administration, delivery to the lung and delivery to the GI tract of a patient, as well as for treating inflammatory disease, such as arthritis or COPD. |
申请公布号 |
US9562090(B2) |
申请公布日期 |
2017.02.07 |
申请号 |
US201313763768 |
申请日期 |
2013.02.11 |
申请人 |
Domantis Limited |
发明人 |
Jespers Laurent;Pupecka Malgorzata;Enever Carolyn;Tomlinson Ian |
分类号 |
A61K39/395;C07K16/00;C07K16/22;C07K16/28;A61M15/08;A61M16/14 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
Octavio Leah M.;Lockenour Andrea V. |
主权项 |
1. A pulmonary formulation comprising an immunoglobulin single variable domain that comprises the amino acid sequence shown in SEQ ID NO: 224, in a particle having a size of 6 μm or less. |
地址 |
Brentford GB |